From “Flat” to Favorable: How Medicare Advantage Payments Increased in the Calendar Year (CY) 2027 Rate Announcement
How CMS Policies to Reverse Protections for Medicare Beneficiaries Reflect a Broader Deregulatory Push
An Uneven Playing Field: Why Smaller Plans Are Calling for Stronger Guardrails on Medicare Advantage Marketing
CMS Suspends New Medicare Advantage Prior Authorization Transparency Rules Amid Public Concerns About Care Denials
Implications of measuring Medicare Advantage quality at the contract level: What that means for beneficiary choices and plan payments
The Trump Administration’s First Regulatory Action on Medicare Advantage Omits Some Prior Authorization Guardrails
Policy options to cover anti-obesity drugs: Highlighting the Georgetown policy compendium as a resource
Privatizing Medicare: Challenges and Unanswered Questions about Default Enrollment into Medicare Advantage
Did Changes From the Inflation Reduction Act Affect Medicare Beneficiaries’ Plan Decisions During Open Enrollment? Reflections From Two SHIP Counselors
